
Soligenix Stock Surges 72% as ThermoVax Vaccine Platform Eyes Ebola Crisis
Soligenix stock surged 72% after announcing its ThermoVax vaccine platform can rapidly address Bundibugyo virus outbreak in Congo with proven primate protection.
SNGXorphan drug designationvaccine development